CINXE.COM
Cell Line Development with Advanced Cell Line Engineering
<!doctype html><html lang="en"><head> <meta charset="utf-8"> <title>Cell Line Development with Advanced Cell Line Engineering</title> <link rel="shortcut icon" href="https://oxfordglobal.com/hubfs/OXFORD_GLOBAL-LOGO_SYMBOL.jpg"> <meta name="description" content="Clonality for regulatory approval means the industry must look towards streamlining and optimising clone selection efficacy."> <meta name="viewport" content="width=device-width, initial-scale=1"> <meta property="og:description" content="Clonality for regulatory approval means the industry must look towards streamlining and optimising clone selection efficacy."> <meta property="og:title" content="Cell Line Development with Advanced Cell Line Engineering"> <meta name="twitter:description" content="Clonality for regulatory approval means the industry must look towards streamlining and optimising clone selection efficacy."> <meta name="twitter:title" content="Cell Line Development with Advanced Cell Line Engineering"> <style> a.cta_button{-moz-box-sizing:content-box !important;-webkit-box-sizing:content-box !important;box-sizing:content-box !important;vertical-align:middle}.hs-breadcrumb-menu{list-style-type:none;margin:0px 0px 0px 0px;padding:0px 0px 0px 0px}.hs-breadcrumb-menu-item{float:left;padding:10px 0px 10px 10px}.hs-breadcrumb-menu-divider:before{content:'›';padding-left:10px}.hs-featured-image-link{border:0}.hs-featured-image{float:right;margin:0 0 20px 20px;max-width:50%}@media (max-width: 568px){.hs-featured-image{float:none;margin:0;width:100%;max-width:100%}}.hs-screen-reader-text{clip:rect(1px, 1px, 1px, 1px);height:1px;overflow:hidden;position:absolute !important;width:1px} </style> <link rel="stylesheet" href="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/135726131582/1732113079147/git/og-stage/css/main.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/fontawesome.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/brands.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/solid.min.css"> <!-- Editor Styles --> <style id="hs_editor_style" type="text/css"> #hs_cos_wrapper_module_17019620504109 { display: block !important; margin-bottom: 0px !important } </style> <!-- Added by GoogleAnalytics4 integration --> <script> var _hsp = window._hsp = window._hsp || []; window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} var useGoogleConsentModeV2 = true; var waitForUpdateMillis = 1000; if (!window._hsGoogleConsentRunOnce) { window._hsGoogleConsentRunOnce = true; gtag('consent', 'default', { 'ad_storage': 'denied', 'analytics_storage': 'denied', 'ad_user_data': 'denied', 'ad_personalization': 'denied', 'wait_for_update': waitForUpdateMillis }); if (useGoogleConsentModeV2) { _hsp.push(['useGoogleConsentModeV2']) } else { _hsp.push(['addPrivacyConsentListener', function(consent){ var hasAnalyticsConsent = consent && (consent.allowed || (consent.categories && consent.categories.analytics)); var hasAdsConsent = consent && (consent.allowed || (consent.categories && consent.categories.advertisement)); gtag('consent', 'update', { 'ad_storage': hasAdsConsent ? 'granted' : 'denied', 'analytics_storage': hasAnalyticsConsent ? 'granted' : 'denied', 'ad_user_data': hasAdsConsent ? 'granted' : 'denied', 'ad_personalization': hasAdsConsent ? 'granted' : 'denied' }); }]); } } gtag('js', new Date()); gtag('set', 'developer_id.dZTQ1Zm', true); gtag('config', 'G-43QK8SYTST'); </script> <script async src="https://www.googletagmanager.com/gtag/js?id=G-43QK8SYTST"></script> <!-- /Added by GoogleAnalytics4 integration --> <link rel="canonical" href="https://oxfordglobal.com/nextgen-biomed/resources/cell-line-development-with-advanced-cell-line-engineering"> <meta property="og:image" content="https://oxfordglobal.com/hubfs/Website/Images/Resources/Cell%20and%20Gene/Cell-Line-Engineering-and-Cell-Clones-min.jpg"> <meta name="twitter:image" content="https://oxfordglobal.com/hubfs/Website/Images/Resources/Cell%20and%20Gene/Cell-Line-Engineering-and-Cell-Clones-min.jpg"> <meta property="og:url" content="https://oxfordglobal.com/nextgen-biomed/resources/cell-line-development-with-advanced-cell-line-engineering"> <meta name="twitter:card" content="summary"> <meta http-equiv="content-language" content="en"> <meta name="generator" content="HubSpot"></head> <body class="nextgen-biomed"> <div class="body-wrapper hs-content-id-177607186815 hs-site-page page "> <div data-global-resource-path="git/og-stage/templates/partials/header.html"> <header class="website-header "> <div class="navbar"> <div class="navbar-brands"> <a href="/nextgen-biomed" class="logo-link current-brand"> <img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/NextGen%20Biomed.svg" class="logo-image"> <i class="dropdown fa-solid fa-chevron-down"></i> </a> <div class="brands"> <div class="intro"> <h2> Explore our brands </h2> <div class="desc"> Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges. </div> </div> <div class="items"> <div class="item primary-brand"> <a href="/" class="logo-link"><img src="https://oxfordglobal.com/hubfs/logo.jpg" class="logo-image"></a> </div> <div class="item"> <a href="/precision-medicine" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Precision%20Medicine.svg" class="logo-image"></a> </div> <div class="item"> <a href="/discovery-development" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Discovery%20%26%20Development.svg" class="logo-image"></a> </div> <div class="item active-item"> <a href="/nextgen-biomed" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/NextGen%20Biomed.svg" class="logo-image"></a> </div> </div> </div> </div> <div class="flex flex-align-center navbar-nav"> <a href="#" class="navbar-nav-toggle"> <div class="toggle-icons"> <i class="fa-solid fa-bars toggle-open"></i> <i class="fa-solid fa-xmark toggle-close"></i> </div> </a> <ul class="navbar-nav-items"> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Events <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Events.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex-3 divider g-20"> <div class="subnav-item-content bottom-mp-fix"> <h3> In-Person & Online Events </h3> <p>Pivotal moments where high-level industry experts and thought leaders come together for focused knowledge sharing and unparalleled networking opportunities.</p> </div> <div class="subnav-item"> <div class="event-pills"> <a href="/nextgen-biomed/events/nextgen-biomed-2025" class="pill center"> <div class="b">NextGen Biomed 2025</div> <div class="heading-smallcaps"> 12 - 14 Mar 2025 | London, UK </div> </a> <a href="/nextgen-biomed/events/cell-2025" class="pill center"> <div class="b">Cell 2025</div> <div class="heading-smallcaps"> 11-12 Nov 2025 | London, UK </div> </a> </div> </div> </div> <div class="subnav-item flex-2"> <div class="subnav-item-content bottom-mp-fix"> <h3> Online Activities </h3> <p>Our Monthly Science Exchanges and Webinars keep you connected to the conversation.</p> </div> <div class="online-activities-list flex flex-column g-10"> <!-- Individual Online Activity --> <div class="online-activity"> <a href="/nextgen-biomed/online#Process%20Challenges%20in%20ATMP%20Development:%20Overcoming%20Hurdles%20for%20Successful%20Manufacturing" class="cta" target="_blank"> <h3 class="other-resources">01/11/24 - Process Challenges in ATMP Development: Overcoming Hurdles for Successful Manufacturing</h3> </a> </div> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/online" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> All Online Activities</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Community <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Community.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> About </h3> <p>NextGen Biomed is the platform to advance the fields of biologics, vaccines & novel therapeutics approaches, helping to deliver life-saving medicines to patients faster.</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/about" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Community </h3> <p>NextGen Biomed is committed to supporting R&D scientists, as well as drug development and manufacturing experts, working with biologics, peptides, and oligonucleotides to overcome complexities at every stage of the drug product lifecycle.</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/community" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1 "> <div class="subnav-item-content bottom-mp-fix"> <h3> Media Partners </h3> <p>We work with leading journal publications on reciprocal marketing arrangements.</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/media-partners" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Services <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Services.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> In-Person Services </h3> <p>At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/in-person-services" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1"> <div class="subnav-item-content bottom-mp-fix"> <h3> Digital Marketing Services </h3> <p>Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/digital-marketing-services" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Resources <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Resources.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex-2 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Browse All Resources </h3> <p>The latest in from nextgen biomed research & development</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/resources" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> All NextGen Biomed Resources</a> </div> </div> <div class="subnav-item flex-4 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Latest Resources </h3> <div class="resources"> <div class="resource"> <div class="resource-cover"> <a href="/nextgen-biomed/resources/university-college-london-hospitals-begins-clinical-trial-for-one-off-car-t-treatment-for-lupus" class="resource-cover-link"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/NextGen%20Biomed/University%20College%20London%20Hospitals%20Begins%20Clinical%20Trial%20for%20One-Off%20CAR%20T%20Treatment%20for%20Lupus%201.jpg" class="resource-cover-image"> </a> </div> <div class="resource-content"> <h3 class="resource-heading"> <a href="/nextgen-biomed/resources/university-college-london-hospitals-begins-clinical-trial-for-one-off-car-t-treatment-for-lupus">University College London Hospitals Begins Clinical Trial for One-Off CAR T Treatment for Lupus</a> </h3> <div class="resource-abstract"> <span class="resource-date">08/11/24 - </span> The possibility of a one-off treatment for lupus could offer hope to 69,000 patients in the UK. </div> </div> </div> <div class="top-divider"></div> <div class="resource"> <div class="other-resources"><a href="/nextgen-biomed/resources/clesrovimab-shows-positive-results-as-preventative-treatment-for-rsv-in-pre-term-and-full-term-infants">07/11/24 - Clesrovimab Shows Positive Results as Preventative Treatment for RSV in Pre-Term and Full-Term Infants</a></div> </div> <div class="top-divider"></div> <div class="resource"> <div class="other-resources"><a href="/nextgen-biomed/resources/the-nist-awards-1-5-million-to-improve-standardisation-in-regenerative-medicine">31/10/24 - The NIST Awards $1.5 Million to Improve Standardisation in Regenerative Medicine</a></div> </div> </div> </div> </div> <div class="subnav-item flex-3"> <div class="subnav-item-content bottom-mp-fix"> <h3> Featured Resource </h3> <div class="resources flex flex-column g-5"> <a href="https://oxfordglobal.com/nextgen-biomed/resources/sponsored/webinar/wuxibiologics/sp-webinar-optimizing-bispecific-antibody-production-from-identifying-optimal-pairings-to-scale-up-processes"> <div class="sponsor-resource flex-column"> <div class="resource-cover img-fluid"> <div class="sponsor-resource-cover-link"> <img src="https://oxfordglobal.com/hubfs/Digital%20Marketing/Webinars/Email%20and%20Social%20Collateral/NGB%20-%20Wuxi%20Biologics/WuXi%20Biologics.png" class="sponsor-resource-cover-image"> </div> </div> <div class="resource-content p-15"> <h3 class="resource-heading"> Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes </h3> <div class="resource-abstract"> On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics </div> </div> </div> </a> </div> </div> </div> </div> </div> </li> <li class="navbar-nav-item show-sm hide-md hide-lg hide-xl"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});" class="navbar-nav-item-link">Contact</a> </li> <li class="navbar-nav-item show-sm hide-md hide-lg hide-xl"> <a href="#" class="navbar-nav-item-link">Our Brands <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-items"> <h2> Explore our brands </h2> <div class="desc"> Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges. </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/">Oxford Global</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/precision-medicine">Precision Medicine</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/discovery-development">Discovery & Development</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/nextgen-biomed">NextGen Biomed</a> </div> </div> </div> </div> </li> </ul> </div> <div class="flex flex-align-center hide-sm show-md show-lg show-xl"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});" class="navbar-button">Contact</a> </div> </div> </header></div> <main id="main-content"> <div class="resource-single"> <div class="header bg-primary-light"> <div class="container-wrapper"> <div class="wide-container header-container"> <div class="header-content flex-1"> <div class="heading-smallcaps"> Cell Line Development | Industry Spotlights & Insight Articles </div> <h1 class="heading"> Cell Line Development with Advanced Cell Line Engineering </h1> <div class="byline"> Edited by Tia Byer | 28 February 2022 </div> <div class="abstract"> The need to demonstrate clonality for regulatory approval means that now more than ever, the industry must look towards streamlining and optimising clone selection efficacy. We sat down with senior representatives from Ichnos Sciences and Sanofi to learn how. </div> </div> <div class="header-graphic flex-1"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Cell%20and%20Gene/Cell-Line-Engineering-and-Cell-Clones-min.jpg" class="header-graphic-image"> </div> </div> </div> </div> <div class="container-wrapper"> <div class="wide-container"> <div class="content"> <div class="content-body text-gap"> <!-- wp:paragraph --> <p>The Cell Line Development market is projected to reach 10,700 million USD by 2027, at a CAGR of 12.5%. Clone selection is a crucial step in cell line development and engineering; it enables stable cell line generation and is closely monitored by regulatory associations. The quality of clone selection is a major factor in assessing and determining the safety and efficacy of a drug product, and as such, there is market interest in increasing efficiency and streamlining the process with advanced cell line engineering. </p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Key players in the field include Lonza, Thermo Fisher Scientific, Sigma-Aldrich Corporation, Selexis SA, Promega, Corning, WuXiAppTec, and Sartorious. In this article, we delve into some of the current challenges and opportunities facing the industry in this paramount area of cell line development.</p> <!-- /wp:paragraph --> <!-- wp:heading --> <h2 id="h-challenges-of-increasing-clone-selection-efficacy">Challenges of Increasing Clone Selection Efficacy:</h2> <!-- /wp:heading --> <!-- wp:paragraph --> <p>One of the biggest unmet challenges in clone selection today is the lack of deep knowledge of cells during early-stage processing. In particular, understanding the changes in expression that occur during pool stage selection is crucial for determining the efficacy of late-stage development. According to Megane Peltret, Senior Officer at Ichnos Sciences, such “changes could be a result of background processes and feeds, or from the DNA, we just don't have the depth of knowledge at the moment to reach an informed conclusion”. </p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Other considerations and determining factors may include the novel format or whether the linker used between the Fragment Crystallizable (FC), and a particular molecule is causing the issue. When it comes to addressing these novel complexities, unanswered questions remain.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Developing high throughput platforms for transient expression likewise presents a hurdle. Despite their promise to screen hundreds of discovery hits to comprehend molecular behaviour, the road to clone selection remains a long and arduous one. </p> <!-- /wp:paragraph --> <!-- wp:heading --> <h2>Fitting the Molecule to High Throughput: Impediment or Solution?</h2> <!-- /wp:heading --> <!-- wp:paragraph --> <p>“Trying to have one platform to fit all molecules is a considerable challenge”, Peltret claimed. “You cannot always guarantee the outcome, and because of Murphy's Law, as you will, not everything can expect to go to plan”, she continued. Minimising the difficulties of establishing an authoritative and all-encompassing process requires forethought. Pharma companies must pre-empt what part of the process will impact sales, how to make the metabolic pathways grow faster, and the repercussions this will have on expression. </p> <!-- /wp:paragraph --> <!-- wp:quote {"className":"is-style-large"} --> <blockquote class="wp-block-quote is-style-large"><p>Understanding the changes in expression that occur during pool stage selection is crucial for determining the efficacy of late-stage development.</p></blockquote> <!-- /wp:quote --> <!-- wp:paragraph --> <p>There needs to be a balance between speed and selection of bespoke molecules. When done correctly, this approach will enable troubleshooting; as Peltret explains, “to develop deep knowledge of every aspect of the process, means you will have a degree of control and when challenges occur early on there will be a more efficient way of correcting them”. Splitting up and analysing every workflow stage will foster and facilitate a more profound and actionable understanding of clone selection optimisation.</p> <!-- /wp:paragraph --> <!-- wp:heading --> <h2>Advancing Complex Molecules During Cloning:</h2> <!-- /wp:heading --> <!-- wp:paragraph --> <p>With an explosion of novel formats coming through the discovery pipeline, Saurabh Sen, Associate Director of Cell Line Development at the Genomic Medicine Unit CMC, Sanofi, is of the opinion that “enhancing the ability to pass on relevant hits with a minimal CMC package is highly beneficial, and there is definitely room for improvement as the process is very tedious at this point in time and very labour intensive”. </p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Automating the process, however, is one way forward. Sen explains how “one of the biggest challenges we are tasked with as an industry is to provide a solution for improving automation, so we can build a next-generation process or a platform to speed up the timeline”.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>These streamlining efforts would encompass the cloning stage (of the early discovery hits at Research) up to the plasmid generation phase to determine how quickly the final high producer clones can be reached. Though to keep in mind that this is done in a transient setting at this point.</p> <!-- /wp:paragraph --> <!-- wp:list --> <ul><li><a href="https://oxfordglobal.com/cell/resources/next-generation-cell-culture-process-development/" target="_blank" rel="noreferrer noopener">What will the Future of Cell Culture Process Development look like? </a></li><li><a href="https://oxfordglobal.com/cell/resources/next-generation-of-aav-vectors-for-human-gene-therapy/" target="_blank" rel="noreferrer noopener">Discover the Legacy and Future Possibilities of AAV Vectors for the Human Gene Therapy Market</a></li><li><a href="https://oxfordglobal.com/cell/resources/cell-line-engineering/" target="_blank" rel="noreferrer noopener">Read the Full Report of our Exclusive ‘Cell Line Engineering' Discussion Report </a></li></ul> <!-- /wp:list --> <!-- wp:paragraph --> <p></p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Prior to process modulation and moving hits into the next stages, it is possible to address the molecule expressibility upfront by conducting a transient linear expression cassette. This will help determine, depending on whether the complex molecule has multiple chains, the necessity of utilising an easy expressing system during the engineering stage. </p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>It also allows scientists to anticipate ahead of time whether to introduce a different leader peptide, change the composition of the linker, or conduct titration of the different chains of the molecule. Speaking on this, Sen noted that “from my own experience, modulating the different parameters, I've seen this increase the titers and product quality of the whole molecule”.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>He continued, “if you are getting approximately 50% of heterodimers, which are your molecules of interest, it relatively bumps up to a higher % of the right species with modulation of various parameters, which will definitely enhance the total productivity &yield for that given molecule”. Additionally, if the transient system should express at 150 mg/litre, molecules can easily increase to multiple gm/L, once stable expression is reached. </p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Therefore, prior to the final molecular design, the role played in transient is significant for increasing productivity. The transient platform will provide an early indication as to whether the molecule has the optimal configuration in order to express it.</p> <!-- /wp:paragraph --> <!-- wp:heading --> <h2>What Will the Future of Cell Line Development Look Like?</h2> <!-- /wp:heading --> <!-- wp:paragraph --> <p>The industry is facing an increasing need for stable cells lines for Biologics and producer cell lines for gene therapy. It is accepted that stable cell lines produce and ensure therapeutic potential. The need to demonstrate clonality for regulatory approval has meant that now more than ever, the industry must look towards streamlining and optimising clone selection efficacy. </p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>The integrity of clone selection for biopharmaceutical development means that the next couple of years will be exciting ones. With novel platforms and emerging pipelines entering the cell and gene therapy landscape, the future looks promising, and we at <a href="https://oxfordglobal.com/" target="_blank" rel="noreferrer noopener">Oxford Global</a> have our eyes firmly peeled.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p><em>Want to find out more about the latest cell therapy news? Register now for our </em><a href="https://oxfordglobal.com/cell-series-uk/" target="_blank" rel="noreferrer noopener"><em>Cell UK: In-Person</em></a><em> event to advance your understanding of cell-based products to ensure clinical and commercial success.</em></p> <!-- /wp:paragraph --> <div class="content-body-footer"> </div> </div> <div class="content-sidebar"> <div class="related-articles"> <h3 class="center">Related Resources</h3> <div class="article"> <a href="/nextgen-biomed/resources/univercell-engineering-red-blood-cells-for-targeted-therapy"> <div class="cover-graphic"> <img src="https://oxfordglobal.com/hubfs/UNIVERCell%20Engineering%20Red%20Blood%20Cells%20for%20Targeted%20Therapy.png" class="cover-graphic-image"> </div> </a><div class="content"><a href="/nextgen-biomed/resources/univercell-engineering-red-blood-cells-for-targeted-therapy"> <h4> UNIVERCell: Engineering Red Blood Cells for Targeted Therapy </h4> <div class="abstract"> Scarlet Therapeutics uses genetic manipulation of red blood cells to carry a higher load of therapeutic proteins to help treat rare metabolic diseases. </div> <div class="read-more"> <a href="/nextgen-biomed/resources/univercell-engineering-red-blood-cells-for-targeted-therapy" class="read-more-link">Read More</a> </div></a> </div> </div> <div class="article"> <a href="/nextgen-biomed/resources/enhancing-gene-editing-efficiency-multi-tailed-mrna-integration-in-crispr-cas9-systems"> <div class="cover-graphic"> <img src="https://oxfordglobal.com/hubfs/Enhancing%20Gene%20Editing%20Efficiency%20Multi%20Tailed%20mRNA%20Integration%20in%20CRISPR%20Cas9%20Systems.png" class="cover-graphic-image"> </div> </a><div class="content"><a href="/nextgen-biomed/resources/enhancing-gene-editing-efficiency-multi-tailed-mrna-integration-in-crispr-cas9-systems"> <h4> Enhancing Gene Editing Efficiency: Multi-Tailed mRNA Integration in CRISPR-Cas9 Systems </h4> <div class="abstract"> A study conducted by the Broad Institute and the Massachusetts Institute of Technology (MIT) demonstrated that when multi-tailed mRNAs were integrated into a CRISPR-Cas9 system they proved to be more efficient gene editors than unmodified mRNA. </div> <div class="read-more"> <a href="/nextgen-biomed/resources/enhancing-gene-editing-efficiency-multi-tailed-mrna-integration-in-crispr-cas9-systems" class="read-more-link">Read More</a> </div></a> </div> </div> </div> </div> </div> </div> </div> </div> <div class="newsletter-cta"> <h2 class="heading">Subscribe to our newsletter</h2> <div class="message"> Sign up for our monthly Newsletter to keep up with all things NextGen Biomed </div> <div class="button-wrapper"> <a href="#" class="button hs-cta-trigger-button hs-cta-trigger-button-177053686099">Newsletter Sign-Up</a> </div> </div> </main> <div data-global-resource-path="git/og-stage/templates/partials/footer.html"><footer class="website-footer flex flex-column g-20"> <div class="footer-columns"> <div class="footer-column"> <a href="https://oxfordglobal.com" class="site-logo-link"> <img src="https://oxfordglobal.com/wp-content/uploads/2023/03/Oxford-Global-Logo-Stacked-Websize.png" class="site-logo"> </a> </div> <div class="footer-column"> <h3>Brands</h3> <ul> <li> <a href="/precision-medicine/">Precision Medicine</a> </li> <li> <a href="/discovery-development/">Discovery & Development</a> </li> <li> <a href="/nextgen-biomed/">NextGen Biomed</a> </li> </ul> </div> <div class="footer-column"> <h3>Services</h3> <ul> <li> <a href="https://oxfordglobal.com/in-person-services/"> In-Person Services </a> </li> <li> <a href="https://oxfordglobal.com/digital-marketing-services/"> Digital Marketing Services </a> </li> </ul> <h3>Upcoming Events</h3> <ul> <li> <a href="https://oxfordglobal.com/calendar/"> Event Calendar </a> </li> </ul> </div> <div class="footer-column"> <h3>Company</h3> <ul> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/about-us/"> About </a> </li> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/vacancies/"> Vacancies </a> </li> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/csr-policy/"> CSR Policy </a> </li> <li class="elementor-icon-list-item"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});"> Contact </a> </li> </ul> </div> <div class="footer-column"> <p> <a href="tel:+441865248455">+44 1865 248 455</a><br> <a href="mailto:help@oxfordglobal.com">help@oxfordglobal.com</a> </p> <p> <strong>Our UK Address:</strong><br> Godstow Court<br> Minns Business Park<br> Botley<br> Oxford, OX2 0JB </p> <p> <strong>Our US Address:</strong><br> 100 Cambridge Street<br> 14th Floor<br> Boston<br> MA 02114 </p> </div> </div> <div class="footer-bottom grid g-20"> <div class="span8 span12-sm span12-md flex flex-column g-10"> <div class="copyright"> © Oxford Global Marketing Ltd. All rights reserved. </div> <ul class="legal-links flex flex-row g-30 flex-column-sm g-sm-10"> <li><a href="https://oxfordglobal.com/legal/">Terms & Conditions</a></li> <li><a href="https://oxfordglobal.com/legal/privacy-policy/">Privacy Policy</a></li> <li><a href="https://oxfordglobal.com/legal/website-terms/">Cookies</a></li> <li><a href="https://www.wishagency.co.uk/" target="_BLANK">Digital Agency Wish</a></li> </ul> </div> <div class="span4 span12-sm span12-md flex-align-end"> <ul class="social-links flex flex-row flex-justify-end flex-justify-center-sm flex-justify-center-md g-30"> <li><a href="https://www.facebook.com/OGConferences/" target="_BLANK"><i class="fa-brands fa-square-facebook"></i></a></li> <li><a href="https://www.linkedin.com/company/oxford-global/" target="_BLANK"><i class="fa-brands fa-linkedin"></i></a></li> <li><a href="https://twitter.com/OGConferences" target="_BLANK"><i class="fa-brands fa-square-x-twitter"></i></a></li> </ul> </div> </div> </footer></div> </div> <script src="/hs/hsstatic/jquery-libs/static-1.1/jquery/jquery-1.7.1.js"></script> <script>hsjQuery = window['jQuery'];</script> <!-- HubSpot performance collection script --> <script defer src="/hs/hsstatic/content-cwv-embed/static-1.1293/embed.js"></script> <script src="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/182600797781/1731148644227/git/og-stage/js/inlineSVG.min.js"></script> <script src="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/135724366742/1725380923802/git/og-stage/js/main.min.js"></script> <script> function getVideoId(url) { var regExp = /^.*(youtu.be\/|v\/|u\/\w\/|embed\/|watch\?v=|\&v=)([^#\&\?]*).*/; var match = url.match(regExp); if (match && match[2].length == 11) { return match[2]; } else { return false; } } function getVideoEmbed(id) { return '<iframe src="https://www.youtube.com/embed/' + id + '" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" allowfullscreen style="aspect-ratio: 16 / 9; width: 100%;"></iframe>'; } jQuery("div.content-body .wp-block-embed__wrapper:contains('youtu')").each(function() { var yt_url = $(this).html().trim(); var yt_id = getVideoId(yt_url); var yt_embed = getVideoEmbed(yt_id); $(this).html(yt_embed); }); </script> <!-- Start of HubSpot Analytics Code --> <script type="text/javascript"> var _hsq = _hsq || []; _hsq.push(["setContentType", "standard-page"]); _hsq.push(["setCanonicalUrl", "https:\/\/oxfordglobal.com\/nextgen-biomed\/resources\/cell-line-development-with-advanced-cell-line-engineering"]); _hsq.push(["setPageId", "hubdb-177607186815-30817717-181072999076"]); _hsq.push(["setContentMetadata", { "contentPageId": "hubdb-177607186815-30817717-181072999076", "legacyPageId": "hubdb-177607186815-30817717-181072999076", "contentFolderId": null, "contentGroupId": null, "abTestId": null, "languageVariantId": 177607186815, "languageCode": "en", }]); </script> <script type="text/javascript" id="hs-script-loader" async defer src="/hs/scriptloader/8696823.js"></script> <!-- End of HubSpot Analytics Code --> <script type="text/javascript"> var hsVars = { render_id: "067b52f9-12a6-450c-88b2-34ae605de63f", ticks: 1732669318773, page_id: 177607186815, dynamic_page_id: "hubdb-177607186815-30817717-181072999076", content_group_id: 0, portal_id: 8696823, app_hs_base_url: "https://app.hubspot.com", cp_hs_base_url: "https://cp.hubspot.com", language: "en", analytics_page_type: "standard-page", scp_content_type: "", analytics_page_id: "hubdb-177607186815-30817717-181072999076", category_id: 1, folder_id: 0, is_hubspot_user: false } </script> <script defer src="/hs/hsstatic/HubspotToolsMenu/static-1.354/js/index.js"></script> </body></html>